Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Prins

Showing results (151-160 of 560) with videos related to

Pageof 56
Sort By:
Journal of Thrombosis and Haemostasis : JTH|August 17, 2005
Medical management of peripheral arterial diseaseB L W Bendermacher, E M Willigendael, J A W Teijink, et al.
Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
Is contrast venography a valid surrogate outcome measure in venous thromboembolism prevention studies?A E M Segers, M H Prins, A W A Lensing, et al.
The Cochrane Database of Systematic Reviews|September 27, 2017
Compression therapy for prevention of post-thrombotic syndromeDiebrecht Appelen, Eva van Loo, Martin H Prins, et al.
Plos One|November 30, 2018
Adverse event detection by medical record review is reproducible, but the assessment of their preventability is notDorthe O Klein, Roger J M W Rennenberg, Richard P Koopmans, et al.
The Cochrane Database of Systematic Reviews|October 30, 2003
Compression therapy for treating stage I and II (Widmer) post-thrombotic syndromeD N Kolbach, M W C Sandbrink, H A M Neumann, et al.
BMJ Open Quality|June 18, 2019
Limited external reproducibility restricts the use of medical record review for benchmarkingDorthe O Klein, Roger Rennenberg, Rijk Gans, et al.
Thrombosis and Haemostasis|November 2, 1999
Which is the outcome of the post-thrombotic syndrome?P Prandoni, A W Lensing, M H Prins, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2006
Differential effects of 5-hydroxytryptamine4 receptor agonists at gastric versus cardiac receptors: an operational framework to explain and quantify organ-specific behaviorJoris H De Maeyer, Nicolaas H Prins, Jan A J Schuurkes, et al.
The Cochrane Database of Systematic Reviews|April 21, 2006
Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudicationB L W Bendermacher, E M Willigendael, J A W Teijink, et al.
The Cochrane Database of Systematic Reviews|March 1, 2002
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolismJ F van der Heijden, B A Hutten, H R Büller, et al.
Pageof 56

Showing results (151-160 of 560) with videos related to

Sort By:
Pageof 56
Journal of Thrombosis and Haemostasis : JTH|August 17, 2005
Medical management of peripheral arterial diseaseB L W Bendermacher, E M Willigendael, J A W Teijink, et al.
Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
Is contrast venography a valid surrogate outcome measure in venous thromboembolism prevention studies?A E M Segers, M H Prins, A W A Lensing, et al.
The Cochrane Database of Systematic Reviews|September 27, 2017
Compression therapy for prevention of post-thrombotic syndromeDiebrecht Appelen, Eva van Loo, Martin H Prins, et al.
Plos One|November 30, 2018
Adverse event detection by medical record review is reproducible, but the assessment of their preventability is notDorthe O Klein, Roger J M W Rennenberg, Richard P Koopmans, et al.
The Cochrane Database of Systematic Reviews|October 30, 2003
Compression therapy for treating stage I and II (Widmer) post-thrombotic syndromeD N Kolbach, M W C Sandbrink, H A M Neumann, et al.
BMJ Open Quality|June 18, 2019
Limited external reproducibility restricts the use of medical record review for benchmarkingDorthe O Klein, Roger Rennenberg, Rijk Gans, et al.
Thrombosis and Haemostasis|November 2, 1999
Which is the outcome of the post-thrombotic syndrome?P Prandoni, A W Lensing, M H Prins, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2006
Differential effects of 5-hydroxytryptamine4 receptor agonists at gastric versus cardiac receptors: an operational framework to explain and quantify organ-specific behaviorJoris H De Maeyer, Nicolaas H Prins, Jan A J Schuurkes, et al.
The Cochrane Database of Systematic Reviews|April 21, 2006
Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudicationB L W Bendermacher, E M Willigendael, J A W Teijink, et al.
The Cochrane Database of Systematic Reviews|March 1, 2002
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolismJ F van der Heijden, B A Hutten, H R Büller, et al.
Pageof 56